Moreover, both conditions share key aspects of immune regulation, notably elevated T-cell-mediated responses and inflammatory cytokines like TNFα, IL-6, and IL-1β, reflecting an increased cardiovascular disease risk in ankylosing spondylitis patients (4, 18, 32). Here, IL6 is linked to ankylosing spondylitis.